Biosensors & POCT– category –
-
Graphene Field-Effect Transistor Biosensors Advance Clinical Applications: Enabling Label-Free, High-Sensitivity Disease Biomarker Detection
PMC Switzerland Overview Graphene Field-Effect Transistor (GFET) biosensors are emerging as a promising platform for early disease diagnosis due to their high sensitivity, label-free detection, and compatibility with point-of-care testin... -
Nanobiosensors Revolutionize Soil and Plant Health Monitoring: Real-time Detection Drives Precision Agriculture
Frontiers in Plant Science Switzerland Overview Nanobiosensors are driving next-generation soil and plant health monitoring by enabling real-time detection of physical, chemical, and biological parameters like soil nutrients and plant he... -
FDA Draft IVD Guide Reshapes 510(k) Planning for Portable POCT and Digitally Connected Diagnostic Devices
China Med Device, LLC USA Overview The U.S. FDA released a draft guidance on August 2, 2026, titled 'In Vitro Diagnostic Devices: Classification and Regulatory Pathways Guidance.' This document clarifies the classification and 510(k) sub... -
Flexible Wearable Electrochemical Glucose Sensor Developed for Sweat Analyte Sensing: Advancing Non-Invasive Monitoring
IEEE Xplore Unknown Overview A flexible, screen-printed electrochemical glucose sensor for wearable sweat monitoring has been developed, combining high conductivity with excellent mechanical conformability through optimized conductive in... -
Nature Sensors Review Highlights AI-Powered Closed-Loop Wearable Bioelectronics: Charting a Course for Personalized, Autonomous Healthcare
Facebook (Nature Portfolio) UK Overview A Nature Sensors review article details how AI-powered closed-loop wearable bioelectronics promise to usher in a new era of personalized, autonomous healthcare by integrating real-time biosensing w... -
Philips Expands Open Patient Monitoring Ecosystem, Bolstering Continuous Biomarker Surveillance Beyond the Bedside
Philips Netherlands Overview Philips significantly expanded its open patient monitoring ecosystem through collaborations with multiple partners including Respiree, smartQare, and LifeSignals. This initiative deploys wearable biosensor te... -
Dexcom Achieves 13% Q2 Revenue Growth as FDA Approves OTC Glucose Biosensor Stelo for Pediatric Use
Medical Design and Outsourcing USA Overview Dexcom reported a robust 13% year-over-year revenue growth in Q2 2026, demonstrating the efficacy of its CGM technology in non-insulin-using Type 2 diabetes patients. Concurrently, the U.S. FDA... -
POCT Innovations Accelerate at MEDICA 2026: Biosensors, Imaging AI, and Lab-on-a-Chip Drive Precision Medicine
MEDICA Germany Overview MEDICA 2026 highlights significant advancements in Point-of-Care Testing (POCT), accelerating on-site diagnostics for rapid clinical decision-making. Progress in biosensors, imaging AI, biomarkers, and lab-on-a-ch... -
Wellness CGMs Under Scrutiny: Long-Term Benefits for Non-Diabetics Lack Robust Clinical Evidence
The European Sting Belgium Overview A recent systematic review in the Journal of Medical Internet Research questions the long-term clinical efficacy of continuous glucose monitors (CGMs) for non-diabetics. While CGMs show promise in prom... -
MIT’s Non-Invasive Raman-Based CGM Achieves Accuracy Comparable to Commercial Devices, Signaling Next-Generation Glucose Monitoring Potential
Morld USA Overview MIT researchers have developed a novel Raman-based non-invasive continuous glucose monitoring (CGM) device that reads glucose through the skin without needles. Initial tests demonstrate accuracy comparable to existing ...
